Skip to content

Effect of NIRS-assisted Assessment on Chronic Lower Extremity and Other Chronic Non-healing Ulcers

Investigation of the Predictive Value of Near Infrared Spectroscopy in Chronic Lower Extremity and Other Chronic Non-healing Ulcers

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06702852
Enrollment
221
Registered
2024-11-25
Start date
2024-07-22
Completion date
2025-02-25
Last updated
2025-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcers

Keywords

tissue oxygenation, Near infrared spectroscopy, lower extremity ulcers, ulcers, SnapshotNIR, NIRS, imaging, oxyhemoglobin, deoxyhemoglobin, hemoglobin, oxygen saturation, wound healing

Brief summary

Investigation of the predictive value of Near Infrared Spectroscopy in Chronic Lower Extremity and Other Chronic non-healing Ulcers

Detailed description

The objective of this study is to evaluate the clinical and economical effect of introduction of near-infrared spectroscopy (NIRS) in the diagnostic and treatment protocol of patients with lower extremity (LE) ulcers as well as other chronic non-healing ulcers, and to determine a positive and/or negative predictive value or range of values for NIRS correlating to patient progress and outcomes.

Interventions

DEVICENIRS imaging in addition to SOC

The intervention group will receive the standard of care per the facility Standard Operating Procedures (SOP) with the addition of NIRS imaging utilizing the SnapshotNIR

Sponsors

WoundCentrics LLC
CollaboratorUNKNOWN
Kent Imaging Inc
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Current patients or patients admitted to Christus Wound Care and Hyperbaric Medicine Departments between July 1, 2024, and December 31, 2024, for the treatment of lower extremity ulcers and other chronic non-healing ulcers. * Lower extremity ulcers and chronic non-healing ulcers will be included in the study regardless of the wound/ulcer etiology. Patients may become eligible for the study at any point during their course of treatment.

Exclusion criteria

* Patients who are being treated at multiple research sites simultaneously.

Design outcomes

Primary

MeasureTime frameDescription
Patient health outcomeFrom enrollment to closeout or 12 weeks from enrollment whichever is earlierTo evaluate the impact of the addition of NIRS to the SOP on patient health outcome by comparing between the control and interventional groups

Secondary

MeasureTime frameDescription
Health Economic ImpactFrom enrollment to closeout or 12 weeks from enrollment whichever is earlierTo evaluate the impact of the addition of NIRS to the SOP on treatment plans, interventions, and financial expenses by comparing between the control and interventional groups

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026